In this randomized controlled trial, in older adults with non-ST-segment elevation myocardial infarction (NSTEMI), invasive ...

New research has identified 45 proteins associated with myocardial infarction, and several of them are more strongly ...

Germany: A recent cohort study published in JAMA Network Open has shed light on the comparative outcomes of ticagrelor and ...

Hospitals across the country are on alert for a possible increase in “holiday heart syndrome” illnesses associated with binge ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular ...

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

4.1.1. An MI can trigger an inflammatory response in the heart. This inflammatory response plays a big role in how the heart ...

THE TCW trial has demonstrated that fractional flow reserve (FFR)-guided percutaneous PCI plus TAVI is superior to SAVR plus ...

Patients who do not respond well to clopidogrel might benefit from new drugs such as AZD6140 ... clopidogRel in non-ST-segment Elevation myocardial infarction-2 (DISPERSE-2) is a randomized ...

Of the patients with unstable angina and NSTEMI in our analysis, 5.7% and 12.3%, respectively, presented with atypical symptoms. Coronary angiography and subsequent treatment with ...

Here are the highlights from the 2024 ESC Congress. You can check out more of our coverage and interviews from the meeting by ...